Immunogen reported $-37339000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Astellas Pharma 4503:JP Y 53255M 17425M
AstraZeneca AZN:LN 1954M 415M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Bristol Myers Squibb BMY:US $ 5289M 67M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Exelixis EXEL:US $ 53.26M 71.63M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
Halozyme Therapeutics HALO:US $ 74.11M 17.41M
Immunogen IMGN:US $ -37.34M 6.6M
Intrexon XON:US $ -29.88M 9.76M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Macrogenics MGNX:US $ -52.89M 12.95M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Novartis NVS:US $ 4544M 120M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M